XML 72 R60.htm IDEA: XBRL DOCUMENT v3.20.4

Note 10 - Commitments and Contingencies (Details Textual) shares in Thousands				1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	May 29, 2020 USD ($)	Mar. 31, 2020 USD ($) shares	Nov. 01, 2019 USD ($)	Jan. 31, 2020 USD ($)	May 31, 2016 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019	Jun. 30, 2018	May 01, 2020 USD ($)	Feb. 14, 2020 USD ($)	Feb. 28, 2015 USD ($)
Gain (Loss) from Change in Fair Value of CVR								$ (899,987)
Contractual Obligation, Total						$ 38,320,000		38,320,000
Tris Pharma, Inc. [Member] | Karbinal Agreement [Member]
Supply and Distribution Commitment, Period (Year)			20 years
Supply and Distribution Commitment, Total Royalty, Percentage of Net Sales			23.50%
Supply and Distribution Commitment, Third Party, Royalty, Percentage of Net Sales			8.50%
Supply and Distribution Commitment, Royalty, Percentage of Net Sales											15.00%	15.00%
Supply and Distribution Agreement, Maximum Yearly Make-whole Payment			$ 2,100,000
Supply and Distribution Agreement, Minimum Sales Per Year			70,000
Supply and Distribution Agreement, Make-whole Payment Per Unit for Sales Under Minimum			$ 30
Supply and Distribution Agreement, Maximum Milestone Obligations			3,000,000
Supply and Distribution Agreement, First Milestone, Minimum Net Revenues			40,000,000
Innovus Pharmaceuticals [Member]
Stock Issued During Period, Shares, Contingent Value Rights (in shares) | shares		120
Stock Issued During Period, Value, Contingent Value Rights		$ 2,000,000
Business Combination, Contingent Value Rights, First Revenue Milestone		24,000,000
Gain (Loss) from Change in Fair Value of CVR		$ 300,000				(100,000)	$ (100,000)	(800,000)	$ (800,000)	$ 300,000
Business Combination, Contingent Consideration, Liability, Total														$ 200,000
Novalere [Member] | Innovus Pharmaceuticals [Member]
Business Acquisition, Contingent Consideration, Number of Payments															5
Business Acquisition, Contingent Consideration, Payment Upon Each Sales Milestone															$ 500,000
Business Combination, Contingent Consideration, Liability, Total						200,000		200,000
Prescription Database [Member]
Unrecorded Unconditional Purchase Obligation, Total					$ 1,600,000
Unrecorded Unconditional Purchase Obligation, Term (Year)					3 years
Contractual Obligation, Total						1,278,000		1,278,000
Prescription Database [Member] | The Pediatric Portfolio [Member]
Unrecorded Unconditional Purchase Obligation, Total				$ 600,000
First Pediatric Portfolio Fixed Obligation [Member]
Contractual Obligation, Monthly Payment			86,840
Contractual Obligation, Balloon Payment			15,000,000
Repayments of Fixed Obligation	$ 15,000,000
Second Pediatric Portfolio Fixed Obligation [Member]
Contractual Obligation, Monthly Payment			$ 100,000
Payments for Fixed Obligations to Investor				$ 210,767
Inventories [Member]
Contractual Obligation, Total						1,717,000		1,717,000
Inventories [Member] | Hikma Pharmaceuticals USA, Inc. [Member]
Unrecorded Unconditional Purchase Obligation, Total													$ 1,000,000
Product Milestone Payments [Member]
Contractual Obligation, Total						$ 3,000,000		$ 3,000,000

X

- Definition

The number of payments for contingent consideration under the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessAcquisitionContingentConsiderationNumberOfPayments
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The amount of payment per each sales milestone of contingent consideration of the business acquaition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessAcquisitionContingentConsiderationPaymentUponEachSalesMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The first revenue milestone for contingent value rights of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of balloon payment under contractual obligation.

+ References

No definition available.

+ Details

Name:	aytu_ContractualObligationBalloonPayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of monthly payment under contractual obligation.

+ References

No definition available.

+ Details

Name:	aytu_ContractualObligationMonthlyPayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of gain (loss) from change in fair value of CVR.

+ References

No definition available.

+ Details

Name:	aytu_GainLossFromChangeInFairValueOfCVR
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of cash outflow for fixed obligation to investor.

+ References

No definition available.

+ Details

Name:	aytu_PaymentsForFixedObligationsToInvestor
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of cash outflow for fixed obligations during the period.

+ References

No definition available.

+ Details

Name:	aytu_RepaymentsOfFixedObligation
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The number of shares of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The value of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of net revenues to be reached to trigger the first milestone obligation of the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementFirstMilestoneMinimumNetRevenues
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of make-whole payment per unit for sales under the minimum units for the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMakewholePaymentPerUnitForSalesUnderMinimum
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of milestone obligations of the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMaximumMilestoneObligations
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of make-whole payment per year under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMaximumYearlyMakewholePayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Th minimum amount of units to be sold per year under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMinimumSalesPerYear
Namespace Prefix:	aytu_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Period covered by the supply and distribution commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentPeriod
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The percentage of net sales to be paid for royalties under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentRoyaltyPercentageOfNetSales
Namespace Prefix:	aytu_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The percentage of net sales to be paid by third party for royalties under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentThirdPartyRoyaltyPercentageOfNetSales
Namespace Prefix:	aytu_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The percentage of net sales that is to be paid in total for royalties under the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentTotalRoyaltyPercentageOfNetSales
Namespace Prefix:	aytu_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.

+ References

No definition available.

+ Details

Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

+ Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

+ Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aytu_TrisPharmaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=aytu_KarbinalAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_NovalereMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_PrescriptionDatabaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_ThePediatricPortfolioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_FirstPediatricPortfolioFixedObligationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_SecondPediatricPortfolioFixedObligationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_InventoriesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=aytu_HikmaPharmaceuticalsUsaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_ProductMilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: